|6 Months Ended|
Jun. 30, 2021
|Debt Disclosure [Abstract]|
|Schedule of convertible and non-convertible advances||
The Company’s Debt with Emerald Health Sciences consists of the following:
|Schedule of interest expense||
The Company’s interest expense consists of the following:
Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.
No definition available.